In 2017, the billionaire Tesla CEO claimed in an article on Tim City’s weblog “Wait However Why” that inside 4 years, his new, under-the-radar startup known as Neuralink would have a tool available on the market that may not solely translate ideas into actions on computer systems, but in addition assist remedy “sure extreme mind accidents.” Then, on July 16, 2019, Musk proudly revealed Neuralink’s tech to the general public in a San Francisco launch occasion, promising that human trials would start in 2020. 

These trails didn’t occur, however final 12 months, at a Nov. 30 “Present and Inform” occasion, Musk assured the gang that Neuralink would acquire approval for its tech by the spring. “I may have a Neuralink machine implanted proper now, and also you wouldn’t even know,” he joked.

That gained’t be taking place both. As a result of security issues, the U.S. Meals and Drug Administration (FDA) simply rejected Neuralink’s late 2022 utility to start human trials, Reuters reported Thursday, citing seven unnamed present and former staff.

The FDA’s key issues embody questions on how Neuralink’s know-how will be implanted or eliminated with out damaging the mind in addition to points with the usage of lithium batteries—that are a identified hearth hazard. The regulator additionally warned concerning the potential for the wires that Neuralink makes use of to move electrical alerts from the mind to the pc—known as Hyperlinks—to have unintended results on motion or feeling. 

It’s a significant setback for Musk, however not the tip of his brain-computer interface desires, because the FDA characterised the approval course of as an ongoing dialog, Reuters reported. It’s additionally not an unexpected setback. Tim Harris, a senior fellow at Janelia Analysis Campus and the lead designer of a BCI startup known as Neuropixels, informed Fortune’s Jeremy Kahn and Jonathan Vanian final 12 months that Musk would want to implant a whole bunch of Hyperlinks in every person to make his machine work correctly.

“It’s a main fear from my perspective,” Harris stated. “What number of holes are you able to insert and nonetheless really feel?”

Nonetheless, simply final 12 months, the BCI startup Synchron, after gaining FDA approval in 2021, grew to become the primary firm to implant a chip right into a human’s mind with the aim of enabling individuals with extreme paralysis to regulate computer systems. Microsoft co-founder Invoice Gates and Amazon’s Jeff Bezos are each traders within the firm.

Musk based Neuralink in 2016, and has stated that, sooner or later, individuals will be capable to use his firm’s know-how to “replay recollections” and argued it’s going to even allow somebody with paralysis to use a smartphone quicker than able-bodied individuals.

So as to accomplish this job Musk introduced his well-known hard-nosed tradition to the startup, main nearly all of the scientists he began the venture with to depart the agency. A half-dozen former staff informed Fortune final 12 months that they had been underneath immense stress to fulfill unrealistic deadlines. 

“There was this top-down dissatisfaction with the tempo of progress despite the fact that we had been shifting at unprecedented speeds,” one former worker stated. 

Tim Hanson, a scientist on the Janelia Analysis Campus, who was a part of Neuralink’s founding group, stated the problem is a “mismatch” between the tempo at which primary science can develop and what Musk and Neuralink need achieved.

“Everybody in that entire empire is simply pushed by worry,” one other worker added.

Nonetheless, Neuralink traders stay assured that the corporate’s know-how shall be revolutionary. The startup has acquired over $360 million in funding since its inception, with backing from high-profile traders like Google Ventures—Google’s VC arm, in line with Crunchbase information.

“I undoubtedly would by no means guess towards him,” Bob Nelsen, co-founder of enterprise capital agency ARCH Enterprise Companions, who has invested his personal cash into Neuralink, informed Reuters this week. “If he has some bumps within the street with Neuralink, or some other factor, he’ll regroup and determine it out.”

Discover ways to navigate and strengthen belief in what you are promoting with The Belief Issue, a weekly e-newsletter inspecting what leaders have to succeed. Enroll right here.